Oct 2, 2018
James is the founder and managing
director of Fitzroy Health, a leading international health care
investment and commercialization firm. He has served as an
executive, entrepreneur, and investor in health care firms across
numerous international markets. James sits on the boards of RJ
Health Systems, DosedDaily, Salute Safety, and Flex Health. He was
awarded Entrepreneur of the Year at The Wharton School 2009 WEC
Expo and has been profiled by the Financial Times. James
holds a BA from The University of Melbourne and an MBA from
Columbia Business School.
00:46 Fitzroy Health’s findings in their study of health care
deals in health systems.
01:16 Developing an understanding of what has been working and what
hasn’t been working in health investments.
01:34 Three letters of value creation.
03:15 The lack of success in health care technology innovations and
why.
04:23 “Where there are disruptive approaches to traditional
operational models ... that’s where health systems have proven to
have the best opportunities.”
04:37 The three categories: licensing drugs and devices, licensing
new technologies, creating disruptive models.
05:15 What exactly the Fitzroy Health study was focusing on.
06:40 LP—limited partner, or investor in a private equity fund.
07:15 ONcore Value.